Select edition
Country
Primary focus
Medical condition
Organization type
Stakeholder
Quality
Germany (2)
Organization / System Development
Musculoskeletal/Multiple Sclerosis (MS) (1)
Biotech Company (0)
Payers (usually governmental or public bodies, reimbursement)
Representativeness of stakeholders
Clinical study phase III